The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.
"FDA approves Jupiter Endovascular’s pivotal study for PE treatment" was originally created and published by Medical Device ...
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilizationIRVINE, Calif., Oct. 29, 2024 ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy ...
Thrombolex announced findings from the RESCUE-II trial, which is evaluating the company’s Bashir endovascular catheter to ...
New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive therapy ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...